Improving Trachoma Control Efforts
Forecasting Trachoma Control
This project helps us understand why trachoma, a serious eye infection, is still a problem in some areas and how we can better prevent it worldwide.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11092726 on NIH RePORTER |
What this research studies
This project builds on past efforts to understand why trachoma control programs haven't fully eliminated the disease in all areas. Researchers are using new information from clinical trials and surveys to predict which communities will successfully control trachoma and which might need extra help. They also plan to figure out what special interventions are needed for "hotspot" areas where current methods aren't enough. Finally, the project will create models to better predict if trachoma might return after it's been controlled, helping to improve surveillance.
Who could benefit from this research
Good fit: This research is relevant to individuals, particularly children aged 0-11, living in communities affected by trachoma caused by C. trachomatis.
Not a fit: Patients not living in trachoma-endemic regions or those without active trachoma infection would not directly benefit from these specific control strategy improvements.
Why it matters
Potential benefit: If successful, this work could lead to more effective and tailored strategies for eliminating trachoma, protecting people from blindness, especially children.
How similar studies have performed: This project builds upon successful work from an original grant period, using new data to refine and enhance existing forecasting and intervention strategies.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Lietman, Thomas M — University of California, San Francisco
- Study coordinator: Lietman, Thomas M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.